Clinic
King County Finance
King County Finance was paid $5.66M by Medicaid between Jan 2018 and Dec 2024, across 110 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 15% of everything it billed.
33Billing provider infoKING COUNTY FINANCE
SEATTLE, WA 98104
SEATTLE, WA 98104
33aNPI1922105154assigned 09/20/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$5.66M
24GClaims259,682
24DCodes billed110
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Washington
Rank by total paid#33 of 162
Median peer was paid$704K
This provider vs. median8.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,066 | $335K | |
| 2019 | 6,391 | $147K | |
| 2020 | 2,240 | $54K | |
| 2021 | 34,221 | $786K | |
| 2022 | 68,061 | $1.46M | |
| 2023 | 71,458 | $1.52M | |
| 2024incomplete | 63,245 | $1.37M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 12,348 | 11,514 | $874K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 16,108 | 15,012 | $842K |
| 86480 | 7.6% | 9,467 | 9,420 | $430K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.8% | 18,290 | 13,903 | $270K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.7% | 18,269 | 13,902 | $268K |
| 90739 | 3.5% | 1,992 | 1,991 | $199K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.4% | 4,668 | 3,965 | $194K |
| 90716 | 3.0% | 2,314 | 2,302 | $172K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.7% | 6,859 | 6,829 | $153K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.5% | 1,703 | 1,695 | $142K |
| 91322 | 2.0% | 1,176 | 1,175 | $114K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.0% | 8,959 | 8,899 | $112K |
98 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.9% | 1,294 | $108K |
| 90686 | 1.8% | 6,790 | $103K | |
| 86704 | 1.7% | 9,500 | $95K | |
| 90707 | 1.7% | 1,527 | $94K | |
| 90715 | 1.6% | 3,059 | $90K | |
| 87340 | 1.6% | 9,312 | $89K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.5% | 5,080 | $87K |
| T1020 | Help at home with daily living, billed per day | 1.5% | 4,047 | $85K |
| 90651 | 1.4% | 1,208 | $78K | |
| 90714 | 1.3% | 3,062 | $74K | |
| 86803 | 1.2% | 5,351 | $66K | |
| 86708 | 1.1% | 5,901 | $63K | |
| S9430 | Pharmacy compounding and dispensing services | 1.1% | 1,171 | $62K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.0% | 457 | $58K |
| 36415 | Collection of venous blood by venipuncture | 1.0% | 13,357 | $58K |
| 86706 | <1% | 6,183 | $57K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 732 | $56K |
| 90713 | <1% | 2,590 | $55K | |
| 90480 | <1% | 1,569 | $48K | |
| 80305 | <1% | 5,992 | $42K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 466 | $42K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 591 | $39K |
| 86787 | <1% | 2,828 | $33K | |
| 90746 | <1% | 631 | $27K | |
| 90633 | <1% | 1,811 | $25K | |
| 90744 | <1% | 1,621 | $24K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 342 | $22K |
| 86592 | <1% | 4,798 | $18K | |
| 81025 | <1% | 3,848 | $15K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 361 | $11K |
| 91320 | <1% | 98 | $11K | |
| 90670 | <1% | 873 | $10K | |
| 90688 | <1% | 802 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 826 | $9K |
| 90723 | <1% | 623 | $9K | |
| S4993 | Contraceptive pills for birth control | <1% | 1,115 | $8K |
| 99443 | <1% | 96 | $8K | |
| 0134A | <1% | 325 | $7K | |
| 90710 | <1% | 402 | $6K | |
| 86735 | <1% | 508 | $6K | |
| G2010 | Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment | <1% | 780 | $6K |
| 86765 | <1% | 487 | $6K | |
| 90656 | <1% | 693 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 65 | $5K |
| 0011A | <1% | 153 | $5K | |
| 90619 | <1% | 290 | $4K | |
| 86762 | <1% | 345 | $4K | |
| 90632 | <1% | 106 | $4K | |
| 90671 | <1% | 288 | $4K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 236 | $4K |
| M0201 | Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home | <1% | 111 | $4K |
| 83655 | <1% | 249 | $3K | |
| 90648 | <1% | 275 | $3K | |
| 0012A | <1% | 62 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 54 | $2K |
| 0141A | <1% | 93 | $2K | |
| 85018 | <1% | 1,069 | $2K | |
| 0031A | <1% | 49 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 244 | $2K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 35 | $2K |
| 99441 | <1% | 68 | $2K | |
| 90837 | Psychotherapy session, about an hour | <1% | 17 | $2K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 275 | $2K |
| 90680 | <1% | 192 | $1K | |
| 91321 | <1% | 420 | $1K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $1K |
| 90658 | <1% | 55 | $825.00 | |
| 90672 | <1% | 58 | $740.84 | |
| 87210 | <1% | 157 | $685.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 90 | $670.06 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 27 | $433.21 |
| Q2039 | Influenza virus vaccine, not otherwise specified | <1% | 29 | $420.00 |
| 90697 | <1% | 25 | $374.13 | |
| 86593 | <1% | 91 | $340.33 | |
| 0144A | <1% | 15 | $322.00 | |
| 90685 | <1% | 29 | $251.60 | |
| 90700 | <1% | 25 | $222.55 | |
| 90681 | <1% | 12 | $195.09 | |
| 96127 | <1% | 32 | $180.90 | |
| 90647 | <1% | 12 | $177.21 | |
| 90756 | <1% | 23 | $159.00 | |
| J3490 | Unclassified drugs | <1% | 13 | $139.00 |
| 87205 | <1% | 33 | $133.46 | |
| 90734 | <1% | 12 | $61.86 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 12 | $16.50 |
| 3008F | 0% | 9,088 | $0.00 | |
| 3074F | 0% | 14,647 | $0.00 | |
| 3079F | 0% | 580 | $0.00 | |
| 3075F | 0% | 68 | $0.00 | |
| 3044F | 0% | 24 | $0.00 | |
| 3080F | 0% | 159 | $0.00 | |
| 91303 | 0% | 52 | $0.00 | |
| 91314 | 0% | 180 | $0.00 | |
| 91301 | 0% | 232 | $0.00 | |
| 3078F | 0% | 12,560 | $0.00 | |
| 90611 | 0% | 763 | $0.00 | |
| 3077F | 0% | 260 | $0.00 | |
| 91313 | 0% | 351 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOE, KEVIN (PROVIDER ENROLLMENT SPECIALIST)
| Provider | Location | Paid |
|---|---|---|
| Seattle-King County Dept of Public Health | Seattle, WA | $74.05M |
| Seattle-King County Dept of Public Health | Seattle, WA | $62.95M |
| Seattle King Co Dept of Public Health | Seattle, WA | $157K |
| Seattle-King County Dept of Public Health | Seattle, WA | $133K |
| Seattle-King County Dept of Public Health | Seattle, WA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.